NICE recommends Mirikizumab for moderately to severely active Crohn’s Disease after biologic failure
Mirikizumab is now recommended by NICE for routine NHS use [...]
As healthcare delivery evolves – especially in rural and underserved [...]
New analysis reveals billions risked on overly complex trials that [...]
Ciloa, a pioneer in bioengineering extracellular vesicles (EVs) for innovative [...]
START unveils the Hope Hub, a digital platform connecting patients, [...]
Collaboration aims to support clinical development of platform designed to [...]
New alliance targets early 2026 for first-in-human trial of non-opioid [...]
IntelliSep test from Cytovale shows potential to reshape emergency triage [...]
First-of-its-kind software aims to improve treatment decisions for patients with [...]
Two new studies presented at the 2025 ISMRM Annual Meeting [...]